PFKFB3 expression levels increased on day 3 after MI and then declined in the late post-infarction period, and continuous inhibition of its function by 3PO significantly led to improved cardiac function and fibrotic remodeling on day 28 after MI. The gene discussed is PFKFB3; the disease is myocardial infarction.